| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |